Cover; Half Title; Title Page; Copyright Page; Table of Contents; Foreword; About the Series; Preface; Editors; Contributors; Chapter 1: Applications of Nanostructured Biomaterials; 1.1 Introduction; 1.2 Nanobiomaterials and Their Applications; 1.2.1 Gold Nanoparticles (AuNPs); 1.2.2 Gadolinium Nanoparticles (GdNPs); 1.2.3 Iron Oxide/Magnetic Nanoparticles (IONPs); 1.2.4 Ceramic Nanoparticles (CENPs); 1.2.5 Titanium Oxide Nanoparticles (TiONPs); 1.2.6 Silica Nanoparticles (SiNPs); 1.2.7 Semiconductor-Based Nanoparticles/Quantum Dots (SMNPs/QDs); 1.2.8 Organic/Carbon-Based Nanoparticles (CNPs)
Text of Note
1.3 ConclusionsAcknowledgment; References; Chapter 2: Nanocoutured Metallic Biomaterials and Surface Functionalization of Titanium-Based Alloys for Medical Applications; 2.1 Introduction; 2.2 Metallic Biomaterial Implants; 2.2.1 Historical Progress on Metallic Biomaterials; 2.2.2 Crucial Necessities in Design of Metallic Biomaterials; 2.2.3 Current Metallic Implants and Their Behavior in a Physiological Environment; 2.3 Surface Treatment of Metallic Biomaterials; 2.3.1 Physical Surface Treatments; 2.3.1.1 Magnetron Sputtering Deposition; 2.3.1.2 Pulsed Laser Deposition
Text of Note
2.3.1.3 Lithography Process2.3.1.4 Plasma Spraying; 2.3.2 Mechanical Surface Treatments; 2.3.3 Chemical Surface Treatments; 2.3.3.1 Atomic Layer Deposition; 2.3.3.2 Silanization and Langmuir-Blodgett Deposition; 2.3.3.3 Layer-by-Layer Assembly Approach; 2.3.3.4 Electrochemical Method: Electrochemical Anodization; 2.4 Conclusions; Acknowledgment; References; Chapter 3: Graphene-Polymer Nanocomposites for Biomedical Applications; 3.1 Introduction; 3.2 Properties of Graphene Family; 3.2.1 Physical Properties and Surface Chemistry; 3.2.2 Toxicity and Antimicrobial Properties
Text of Note
3.3 Polymer/Graphene Nanocomposites3.4 Polymer/Graphene Nanocomposite Scaffolds; 3.4.1 Biomedical Applications of Graphene Materials; 3.4.2 Polymer/Graphene Scaffolds; 3.4.3 State-of-the-Art Fabrication Techniques; 3.4.3.1 Graphene/Nanocomposite Scaffolds by Electrospinning; 3.4.3.2 Graphene/Nanocomposite Scaffolds by 3D Printing; 3.4.4 Polymer/Graphene Solid-State Scaffolds and Hydrogel Scaffolds; 3.5 Future Perspectives; Acknowledgments; References; Chapter 4: Lipid-Based Nanocarriers in Lymphatic Transport of Drugs: Retrospect and Prospects; 4.1 Introduction
Text of Note
4.2 Lymphatic Drug Transport System: An Overview4.2.1 Biological Transporters; 4.2.1.1 ABC Transporter (ATP Binding Cassettes Transporter); 4.2.1.1.1 P-glycoprotein (P-gp); 4.2.1.1.2 Multidrug resistance associated proteins (MdPs); 4.2.1.2 SLC Transporters (Solute Carrier Transporter); 4.2.1.3 Coupling Efflux Transporters with Metabolic Enzymes; 4.3 Approaches to Target Drugs via the Lymphatic System; 4.3.1 Lipid-Based Formulations; 4.3.1.1 Emulsions/Microemulsions/SMEDDS/SNEDDS; 4.3.1.2 Lipid Nanoparticles; 4.3.1.3 Liposomes; 4.4 Conclusions; References
0
8
8
8
8
SUMMARY OR ABSTRACT
Text of Note
The present book volume presents a holistic view of the aspects of nanobiomaterials incl. their stellar merits and limitations, applications in diverse fields, their futuristic promise in the fields of biomedical science and drug delivery. The federal & regulatory issues on the usage of nanobiomaterials have been assigned due consideration.